87 related articles for article (PubMed ID: 18024395)
1. Impact of interleukin-10 polymorphisms (-1082 and -3575) on the survival of patients with lymphoid neoplasms.
Domingo-Domènech E; Benavente Y; González-Barca E; Montalban C; Gumà J; Bosch R; Wang SS; Lan Q; Whitby D; Fernández de Sevilla A; Rothman N; de Sanjosé S
Haematologica; 2007 Nov; 92(11):1475-81. PubMed ID: 18024395
[TBL] [Abstract][Full Text] [Related]
2. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
Kube D; Hua TD; von Bonin F; Schoof N; Zeynalova S; Klöss M; Gocht D; Potthoff B; Tzvetkov M; Brockmöller J; Löffler M; Pfreundschuh M; Trümper L
Clin Cancer Res; 2008 Jun; 14(12):3777-84. PubMed ID: 18559596
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas.
Lee JJ; Kim DH; Lee NY; Sohn SK; Kim JG; Kim HJ; Do YR; Park YH
Br J Haematol; 2007 May; 137(4):329-36. PubMed ID: 17408400
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
5. Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy.
Park YH; Sohn SK; Kim JG; Lee MH; Song HS; Kim MK; Jung JS; Lee JJ; Kim HJ; Kim DH
Clin Cancer Res; 2009 Mar; 15(6):2107-15. PubMed ID: 19276283
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 gene polymorphisms influence the clinical course of non-Hodgkin's lymphoma.
Bogunia-Kubik K; Mazur G; Wróbel T; Kuliczkowski K; Lange A
Tissue Antigens; 2008 Feb; 71(2):146-50. PubMed ID: 18201362
[TBL] [Abstract][Full Text] [Related]
7. Influence of cytokine genes polymorphisms on long-term outcome in renal transplantation.
Breulmann B; Bantis C; Siekierka M; Blume C; Aker S; Kuhr N; Grabensee B; Ivens K
Clin Transplant; 2007; 21(5):615-21. PubMed ID: 17845635
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.
Kim JG; Chae YS; Sohn SK; Cho YY; Moon JH; Park JY; Jeon SW; Lee IT; Choi GS; Jun SH
Clin Cancer Res; 2008 Jan; 14(1):62-6. PubMed ID: 18172253
[TBL] [Abstract][Full Text] [Related]
9. Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk.
Nieters A; Beckmann L; Deeg E; Becker N
Genes Immun; 2006 Dec; 7(8):615-24. PubMed ID: 16971956
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-4 promoter polymorphisms: a genetic prognostic factor for survival in metastatic renal cell carcinoma.
Kleinrath T; Gassner C; Lackner P; Thurnher M; Ramoner R
J Clin Oncol; 2007 Mar; 25(7):845-51. PubMed ID: 17327605
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner.
Tedde A; Laura Putignano A; Bagnoli S; Congregati C; Milla M; Sorbi S; Genuardi M; Papi L
Scand J Gastroenterol; 2008; 43(6):712-8. PubMed ID: 18569989
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients.
Ezzidi I; Mtiraoui N; Kacem M; Mallat SG; Mohamed MB; Chaieb M; Mahjoub T; Almawi WY
Clin Endocrinol (Oxf); 2009 Mar; 70(3):401-7. PubMed ID: 18616700
[TBL] [Abstract][Full Text] [Related]
13. Genetic association of interleukin-10 promoter polymorphisms and susceptibility to diffuse large B-cell lymphoma: a meta-analysis.
Cao HY; Zou P; Zhou H
Gene; 2013 May; 519(2):288-94. PubMed ID: 23485354
[TBL] [Abstract][Full Text] [Related]
14. Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults.
Erikstrup C; Kallestrup P; Zinyama-Gutsire RB; Gomo E; Butterworth AE; Pedersen BK; Ostrowski SR; Gerstoft J; Ullum H
AIDS; 2007 Nov; 21(17):2283-91. PubMed ID: 18090276
[TBL] [Abstract][Full Text] [Related]
15. The polymorphisms of interleukin-10 gene influence the prognosis of patients with advanced melanoma.
Vuoristo MS
Cancer Genet Cytogenet; 2007 Jul; 176(1):54-7. PubMed ID: 17574964
[TBL] [Abstract][Full Text] [Related]
16. The combined effect of interleukin (IL)-10 and IL-12 polymorphisms on induced cytokine production.
Miteva L; Stanilova S
Hum Immunol; 2008 Sep; 69(9):562-6. PubMed ID: 18703108
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of TNF and IL-10 genes and clinical outcome of patients with chronic lymphocytic leukemia.
Lech-Maranda E; Mlynarski W; Grzybowska-Izydorczyk O; Borowiec M; Pastorczak A; Cebula-Obrzut B; Klimkiewicz-Wojciechowska G; Wcislo M; Majewski M; Kotkowska A; Robak T; Warzocha K
Genes Chromosomes Cancer; 2013 Mar; 52(3):287-96. PubMed ID: 23225254
[TBL] [Abstract][Full Text] [Related]
19. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.
Al-Moundhri MS; Al-Nabhani M; Burney IA; Al-Farsi AA; Al-Bahrani B
Mol Carcinog; 2009 Dec; 48(12):1170-6. PubMed ID: 19676106
[TBL] [Abstract][Full Text] [Related]
20. Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma.
Wei YS; Lan Y; Luo B; Lu D; Nong HB
Mol Carcinog; 2009 Aug; 48(8):751-7. PubMed ID: 19148899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
